In triple-negative breast cancer, G protein-coupled estrogen receptor (GPER) inhibits cell invasion and angiogenesis by suppressing NF-κB/IL-6 signaling [52]. This evidence concerns the gene NFKB1 and triple-negative breast carcinoma.